SCHEMBL6675952

SCHEMBL6675952

CC(C)(C)OC(=O)NCc1cc(NC(N)=S)ccc1OCc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.45
PTGER1 P34995 1/20 0.45
C5AR1 P21730 6/20 0.45
ALDH1A1 P00352 2/20 0.44
GAA P10253 1/20 0.44
P2RX4 Q99571 1/20 0.43
LMNA P02545 2/20 0.43
MAPT P10636 2/20 0.43
HDAC1 Q13547 1/20 0.43
ALOX12 P18054 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
LTA4H P09960 1/20 0.43
CCR5 P51681 1/20 0.42
NAMPT P43490 1/20 0.41
ESRRA P11474 1/20 0.41
MAPK1 P28482 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
SYK P43405 1/20 0.40
PPARG P37231 1/20 0.40
PPARD Q03181 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6677097 0.86 ALDH1A1 (0.46) ALDH1A1GAAMAPTNAMPTTDP1
SCHEMBL6681429 0.84 C5AR1 (0.47) CYP2C9PTGER1C5AR1P2RX4MAPT
SCHEMBL7247258 0.84 ALDH1A1 (0.56) CYP2C9ALDH1A1GAAP2RX4LMNA
SCHEMBL6681179 0.83 CYP2C9 (0.47) CYP2C9PTGER1ALDH1A1LMNAHDAC1
SCHEMBL6678137 0.83 C5AR1 (0.46) CYP2C9PTGER1C5AR1ALDH1A1GAA
SCHEMBL27564883 0.83 CYP2C9 (0.45) CYP2C9PTGER1C5AR1P2RX4LMNA
SCHEMBL6680473 0.82 CYP2C9 (0.42) CYP2C9PTGER1C5AR1P2RX4LMNA
SCHEMBL6681426 0.81 CYP2C9 (0.42) CYP2C9PTGER1ALDH1A1P2RX4LMNA
SCHEMBL6680475 0.81 CYP2C9 (0.42) CYP2C9PTGER1C5AR1P2RX4LMNA
SCHEMBL3418906 0.81 CCR5 (0.64) PTGER1ALDH1A1LMNACCR5MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0798292-B1 ANILINE DERIVATIVES HAVING NITROGEN MONOXIDE SYNTHASE INHIBITORY ACTIVITY CHUGAI SEIYAKUKABUSHIKI KAISHA (JP) 2004-11-03 EP disclosed
US-6534546-B1 Guanidine- or isothioureido-N-derived anilines; brain, nervous system, and neurodegenerative disorders CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-03-18 US disclosed
CN-1310169-A Anils with nitric oxide synzyme inhibiting function SHUGAI SEIYAKU K K (JP) 2001-08-29 CN disclosed
CN-1172473-A Aniline derivatives having nitric oxide synthase inhibitory activity CHUGAI PHARMACEUTICAL CO LTD (JP) 1998-02-04 CN disclosed
EP-0798292-A1 ANILINE DERIVATIVES HAVING NITROGEN MONOXIDE SYNTHASE INHIBITORY ACTIVITY Chugai Seiyaku Kabushiki Kaisha (JP) 1997-10-01 EP disclosed